The Telangana State Council of Higher Education (TSCHE) will publish the TS EAMCET B.Pharma Phase 1 seat allotment result 2025 on Thursday, September 25, 2025. Candidates who participated in the counselling process can check their allotment order by logging in with their hall ticket and registration details on the official portal, tgeapcetb.nic.in. Although officials have not disclosed the exact timing, counselling experts suggest that the Phase 1 allotment is likely to be released by 3 PM. In case of delays, the results can be expected anytime up to 6 PM or 8 PM.
TS EAMCET B.Pharma Phase 1 Allotment 2025: Expected Release Time
The tentative time slots for the release of the allotment order are mentioned below for candidates’ reference:
Basis of Seat Allotment
The Phase 1 B.Pharmacy allotment result will be prepared based on:
- Candidate’s EAMCET rank
- Seat matrix provided by participating colleges
- Options/preferences filled by the candidate
- Admission policy and reservation rules
This ensures transparency and merit-based allocation of seats across government and private pharmacy colleges in Telangana.
How to Check TS EAMCET B.Pharma Phase 1 Allotment 2025?
Candidates can follow the steps below to download their allotment order:
- Visit the official counselling portal at tgeapcetb.nic.in.
- Click on the link “B.Pharma Phase 1 Seat Allotment 2025” available on the homepage.
- Enter the hall ticket number, registration number, and password.
- Submit the details to view the allotment status.
- Download and print the allotment order for further admission process.
Reporting and Admission
- Candidates allotted seats in Phase 1 must pay the tuition fee online to confirm their admission.
- After fee payment, candidates are required to report to the allotted college for document verification.
- The reporting window for Phase 1 will be open from September 25 to September 26, 2025.
- Those failing to report within the deadline will forfeit their allotted seat, and the same will be included in the next round of counselling.